Global Blood Ther (GBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 92,072 | 148,502 | 52,069 | 3,278 |
| Marketable Securities | 55,202 | N/A | N/A | N/A |
| Other current assets | 512 | 0 | 389 | 66 |
| TOTAL | $149,769 | $149,724 | $53,593 | $3,726 |
| Non-Current Assets | ||||
| PPE Net | 2,420 | 2,114 | 2,023 | 2,366 |
| Investments And Advances | 50,058 | 0 | 0 | 0 |
| Other Non-Current Assets | 140 | 140 | 140 | 80 |
| TOTAL | $52,618 | $2,254 | $2,163 | $2,446 |
| Total Assets | $202,387 | $151,978 | $55,756 | $6,172 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 4,320 | 3,254 | 555 | 974 |
| Accrued Expenses | 10,286 | 5,653 | 1,795 | 925 |
| Other current liabilities | 909 | 720 | 187 | 1,863 |
| TOTAL | $15,515 | $9,627 | $2,537 | $3,762 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 563 | 1,556 | 384 | 159 |
| TOTAL | $563 | $1,556 | $384 | $159 |
| Total Liabilities | $16,078 | $11,183 | $2,921 | $3,921 |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 43,534 | 30,527 | N/A | N/A |
| Common Shares | 37 | 29 | 2 | 1 |
| Retained earnings | -180,933 | -98,465 | -49,328 | -28,047 |
| Other shareholders' equity | -166 | 0 | 102,161 | 28,225 |
| TOTAL | $186,309 | $140,795 | $52,835 | $2,251 |
| Total Liabilities And Equity | $202,387 | $151,978 | $55,756 | $6,172 |